FSA
Fort Sheridan Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-295
| Closed | -$310K | – | 255 |
|
|
2024
Q3 | $310K | Hold |
295
| – | – | 0.05% | 199 |
|
|
2024
Q2 | $310K | Buy |
295
+50
| +20% | +$52.6K | 0.05% | 186 |
|
|
2024
Q1 | $236K | Hold |
245
| – | – | 0.04% | 180 |
|
|
2023
Q4 | $215K | Sell |
245
-50
| -17% | -$43.9K | 0.04% | 183 |
|
|
2023
Q3 | $243K | Hold |
295
| – | – | 0.06% | 162 |
|
|
2023
Q2 | $212K | Hold |
295
| – | – | 0.05% | 182 |
|
|
2023
Q1 | $242K | Hold |
295
| – | – | 0.06% | 167 |
|
|
2022
Q4 | $213K | Hold |
295
| – | – | 0.07% | 172 |
|
|
2022
Q3 | $203K | Buy |
+295
| New | +$203K | 0.07% | 171 |
|
|
2022
Q2 | – | Sell |
-295
| Closed | -$206K | – | 194 |
|
|
2022
Q1 | $206K | Buy |
+295
| New | +$206K | 0.06% | 171 |
|
|
2021
Q4 | – | Sell |
-345
| Closed | -$209K | – | 207 |
|
|
2021
Q3 | $209K | Buy |
+345
| New | +$209K | 0.07% | 171 |
|